Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) progression:
total amount of TAMs and specific phenotype of TAMs identified by functional biomarkers. We
MEAD, G.E.,
LEGG, L.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.,
DENNIS, M.S.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J. (2020) added to the seven trials identified in a 2012 Cochrane review (
total: 13 trials, n = 4145
group. A
total of 20 sophomores (10 each from two universities: Sechenov University, Department
Beylerli, O.A.,
Azizova, S.T.,
Konovalov, N.A.,
Akhmedov, A.D.,
Gareev, I.F.,
Belogurov, A.A. (2020) 20,000 protein-coding genes covering near 2% of the
total genomic sequence. The vast majority of gene
Gareeva, A.E.,
Sharafiev, R.R.,
Akhmetova, E.A.,
Nasibullin, T.R.,
Fakhurtdinova, Z.R.,
Yuldashev, V.L.,
Asadullin, A.R. (2020) -ctivity disorder (ADHD). Materials and methods. A
total of 146 male adolescents consuming synthetic cannabinoids